Skip to content
WeighLab
Menu
Ranked #243 · Grade C

LumiMeds review

LumiMeds is a telehealth platform selling compounded semaglutide 'as low as $99/mo' and compounded tirzepatide 'as low as $183/mo,' both offered across monthly, 3-, 6-, and 12-month payment terms with Klarna financing.

Visit LumiMeds Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$99/mo (starting dose, 12-month plan, compounded)
Tirzepatide
$183/mo (starting dose, prepay plan, compounded)
Coverage
Coverage not published
Brand-name
Compounded only

Semaglutide · modeled / year

$1,188

Tirzepatide · modeled / year

$2,196

Pricing verified August 2026

The Index scorecard

LumiMeds scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month69/100
Price Transparency78/100
Nationwide Access24/100
Formulation Options66/100
Clinical Oversight70/100
Contract Flexibility47/100

Where the value is

  • Named, credentialed Medical Director (Dr. Teresa Walsh, M.D., board certified in obesity medicine, licensed in all 50 states) rather than an anonymous 'board-certified physicians' claim
  • LegitScript Certified and HIPAA compliant
  • No membership requirement or subscription fee stated separately from the medication price
  • Klarna financing and FSA/HSA eligibility both offered
  • Cold-chain shipping specifically called out for tirzepatide

The tradeoffs

  • Both headline prices are explicitly 'as low as' figures across monthly/3/6/12-month options, and the site does not publish what the plain month-to-month rate is versus the prepay-discounted floor — the true standalone monthly cost could not be confirmed
  • Compounded medications are, by the site's own disclosure, 'not FDA-approved and have not been evaluated for safety and effectiveness by the FDA'
  • No specific compounding pharmacy name found on the pages reviewed
  • Exact dose amounts corresponding to the advertised prices are not published on the product pages
  • FDA issued Lumimeds a warning letter in September 2025; the letter is public in FDA's warning-letter database

The bottom line

Best for: Shoppers willing to prepay a longer term to chase the lowest advertised rate, and who value a named, board-certified medical director. LumiMeds is a telehealth platform selling compounded semaglutide 'as low as $99/mo' and compounded tirzepatide 'as low as $183/mo,' both offered across monthly, 3-, 6-, and 12-month payment terms with Klarna financing.

Ranked #243 of 539 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 538 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to LumiMeds.

The 24 programs nearest this one

Pricing, states and verification reflect LumiMeds's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on LumiMeds's site. Not medical advice; see our disclosure.

← Back to the value leaderboard